Raymond James Financial Services Advisors »

Diamedica Therapeutics shares owned by Raymond James Financial Services Advisors

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Raymond James Financial Services Advisors from 13F filings

Historical chart of Raymond James Financial Services Advisors investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Raymond James Financial Services Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Raymond James Financial Services Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $48k 12k 4.19

More positions owned by Raymond James Financial Services Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Value Etf (VTV)
Broadcom (AVGO)
Vanguard Index Fds Total Stk Mkt (VTI)
Home Depot (HD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Wal-Mart Stores (WMT)

View all positions for Raymond James Financial Services Advisors

Top funds holding Diamedica Therapeutics

Vanguard Group
First Manhattan
Paragon Associates & Paragon Associates Ii Joint Venture
Bleichroeder
Geode Capital Management
LPL Financial
Northern Trust
BlackRock
BlackRock
Susquehanna International
Morgan Stanley
State Street Corporation
Ronald Blue Trust
Catalyst Financial Partners
Citigroup

View all funds holding Diamedica Therapeutics